NovaBridge Biosciences Statistics
Total Valuation
NBP has a market cap or net worth of $492.29 million. The enterprise value is $267.29 million.
Important Dates
The next estimated earnings date is Saturday, February 14, 2026, before market open.
| Earnings Date | Feb 14, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
NBP has 115.29 million shares outstanding. The number of shares has increased by 6.88% in one year.
| Current Share Class | n/a |
| Shares Outstanding | 115.29M |
| Shares Change (YoY) | +6.88% |
| Shares Change (QoQ) | +27.55% |
| Owned by Insiders (%) | 5.61% |
| Owned by Institutions (%) | 20.74% |
| Float | 59.97M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| Forward PS | n/a |
| PB Ratio | 1.90 |
| P/TBV Ratio | 1.90 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 14.47, with a Debt / Equity ratio of 0.01.
| Current Ratio | 14.47 |
| Quick Ratio | 14.24 |
| Debt / Equity | 0.01 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | n/a |
| Return on Invested Capital (ROIC) | n/a |
| Return on Capital Employed (ROCE) | -13.29% |
| Revenue Per Employee | n/a |
| Profits Per Employee | -$822,688 |
| Employee Count | 32 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +402.35% in the last 52 weeks. The beta is 1.59, so NBP's price volatility has been higher than the market average.
| Beta (5Y) | 1.59 |
| 52-Week Price Change | +402.35% |
| 50-Day Moving Average | 4.22 |
| 200-Day Moving Average | 2.98 |
| Relative Strength Index (RSI) | 52.41 |
| Average Volume (20 Days) | 528,589 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -34.74M |
| Pretax Income | -26.33M |
| Net Income | -26.33M |
| EBITDA | -34.67M |
| EBIT | -34.74M |
| Earnings Per Share (EPS) | -$0.30 |
Full Income StatementBalance Sheet
The company has $228.27 million in cash and $3.28 million in debt, giving a net cash position of $225.00 million or $1.95 per share.
| Cash & Cash Equivalents | 228.27M |
| Total Debt | 3.28M |
| Net Cash | 225.00M |
| Net Cash Per Share | $1.95 |
| Equity (Book Value) | 258.92M |
| Book Value Per Share | 2.25 |
| Working Capital | 216.68M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$16.95 million and capital expenditures -$45,000, giving a free cash flow of -$17.00 million.
| Operating Cash Flow | -16.95M |
| Capital Expenditures | -45,000 |
| Free Cash Flow | -17.00M |
| FCF Per Share | -$0.15 |
Full Cash Flow StatementMargins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
